Bausch Health Companies Inc (BHC)
5.41 x 10 5.46 x 70
Post-market by (Cboe BZX)
5.41 -0.03 (-0.55%) 04/28/25 [NYSE]
5.41 x 10 5.46 x 70
Post-market 5.46 +0.05 (+0.92%) 18:19 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select FieldsSymbol | BHC | BBIO | SUPN | ||
Company | Bausch Health Companies Inc | Bridgebio Pharma Inc | Supernus Pharm | ||
Price Information | |||||
Exchange | NYSE | NASDAQ | NASDAQ | ||
Open | 5.46 | 36.45 | 32.48 | ||
High | 5.50 | 36.90 | 32.57 | ||
Low | 5.33 | 34.67 | 31.88 | ||
Last | 5.41 | 35.89 | 32.25 | ||
Change | -0.03 | -0.42 | +0.03 | ||
% Change | -0.55% | -1.14% | +0.09% | ||
Volume | 1,640,600 | 3,256,600 | 272,000 | ||
20-Day Average Volume | 3,115,170 | 2,645,635 | 553,275 | ||
Previous Close | 5.44 | 36.31 | 32.22 | ||
Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 5.17 | 33.77 | 31.61 | ||
20-Day Raw Stochastic | 51.10% | 88.21% | 55.19% | ||
20-Day Relative Strength | 44.46% | 55.87% | 49.87% | ||
Weighted Alpha | -39.72 | +36.44 | +1.43 | ||
Today's Opinion | 88% Sell | 80% Buy | 72% Sell | ||
Previous Opinion | 88% Sell | 80% Buy | 72% Sell | ||
Last Month's Opinion | 80% Sell | 88% Buy | 40% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +14.62% since 04/21/25 | +7.10% since 04/21/25 | +6.47% since 04/21/25 | ||
Low | 5.00 on 04/22/25 | 33.55 on 04/22/25 | 30.24 on 04/22/25 | ||
High | 5.49 on 04/28/25 | 36.90 on 04/28/25 | 32.57 on 04/28/25 | ||
1-Month | |||||
%Chg | -16.51% since 03/28/25 | +2.22% since 03/28/25 | -0.12% since 03/28/25 | ||
Low | 4.25 on 04/11/25 | 28.33 on 04/09/25 | 29.77 on 04/09/25 | ||
High | 6.52 on 03/31/25 | 36.90 on 04/28/25 | 34.26 on 04/07/25 | ||
3-Month | |||||
%Chg | -28.82% since 01/28/25 | -1.16% since 01/28/25 | -17.62% since 01/28/25 | ||
Low | 4.25 on 04/11/25 | 28.33 on 04/09/25 | 29.77 on 04/09/25 | ||
High | 7.89 on 02/27/25 | 39.47 on 02/20/25 | 40.28 on 02/05/25 | ||
6-Month | |||||
%Chg | -33.94% since 10/28/24 | +46.85% since 10/28/24 | -5.59% since 10/28/24 | ||
Low | 4.25 on 04/11/25 | 21.72 on 11/19/24 | 29.77 on 04/09/25 | ||
High | 9.85 on 11/04/24 | 39.47 on 02/20/25 | 40.28 on 02/05/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,969,504 | 5,955,783 | 1,827,350 | ||
Shares Outstanding, K | 369,513 | 189,856 | 55,814 | ||
Annual Sales | 9,625,000,000 | 221,900,000 | 661,820,000 | ||
Annual Net Income | -46,000,000 | -535,760,000 | 73,870,000 | ||
Last Quarter Sales | 2,559,000,000 | 5,880,000 | 174,160,000 | ||
Last Quarter Net Income | 93,000,000 | -265,050,000 | 15,330,000 | ||
60-Month Beta | 0.43 | 1.08 | 0.90 | ||
Per-Share Information | |||||
Most Recent Earnings | 1.15 on 02/19/25 | -1.31 on 02/20/25 | 0.75 on 02/25/25 | ||
Latest Earnings Date | 04/30/25 | 04/29/25 | 05/06/25 | ||
Most Recent Dividend | 1.000 on 11/10/10 | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 1.45 | 0.00 | 16.78 |